Farmacias Benavides, S.A.B. de C.V. Share Price
Stocks
BEVIDES B
MXP3895X1106
Drug Retailers
OTC Markets Traded|
End-of-day quote
Mexican S.E.
22/07/2026
|
5-day change | 1st Jan Change | ||
| 25.00 MXN | -.--% |
|
-.--% | -3.85% |
| 10-07 | Canada's Weston family to buy UK's Boots in $8.9 billion deal | RE |
| 07-31 | Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 10.22B 543M 487M 449M 406M 760M 51.75B 772M 5.36B 2.14B 27.08B 2.04B 2B 85.78B | P/E 2024 |
68.9x | P/E 2025 | 47.4x |
|---|---|---|---|---|---|
| Enterprise Value | 11.96B 636M 569M 525M 475M 889M 60.53B 903M 6.27B 2.5B 31.68B 2.39B 2.33B 100B | EV / Sales 2024 |
0.69x | EV / Sales 2025 | 0.64x |
| Free-Float |
16.07% | Yield 2024 * |
-
| Yield 2025 | - |
| 6 months | -3.85% | ||
| Current year | -3.85% |
| Current year | 25 |  | 26 |
| 1 year | 25 | | 26 |
| 3 years | 17.5 | | 26 |
| 5 years | 8.3 | | 26 |
| 10 years | 8.3 | | 26 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/12/2024 | |
| Director of Finance/CFO | - | 16/03/2026 | |
| Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Olmo Palermo
BRD | Director/Board Member | - | 31/12/2020 |
| Chairman | - | 01/05/2023 | |
| Director/Board Member | - | 01/05/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | +31.58% | 548M | |
| -1.26% | -7.55% | -42.15% | +0.64% | 14.81B | |
| +0.22% | -2.00% | -10.54% | -2.79% | 6.26B | |
| +1.65% | -0.07% | -16.89% | +1.72% | 6.16B | |
| -1.25% | -6.13% | -53.78% | -40.62% | 5.75B | |
| -15.53% | -23.72% | -19.75% | -37.61% | 5.11B | |
| +1.16% | -1.68% | -1.14% | -9.60% | 4.53B | |
| -0.81% | -5.52% | -17.46% | -21.21% | 3.02B | |
| -0.16% | +1.88% | +0.99% | -22.99% | 3.15B | |
| -4.44% | -10.93% | -42.24% | -18.73% | 2.99B | |
| Average | -2.04% | -5.63% | -20.30% | -11.96% | 5.23B | |
| Weighted average by Cap. | -2.00% | -6.03% | -26.48% | -12.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.65B 938M 840M 775M 702M 1.31B 89.34B 1.33B 9.25B 3.69B 46.76B 3.52B 3.45B 148B | 19.46B 1.03B 927M 855M 774M 1.45B 98.51B 1.47B 10.2B 4.07B 51.56B 3.88B 3.8B 163B |
| Net income | 131M 6.94M 6.22M 5.73M 5.19M 9.7M 661M 9.86M 68.41M 27.29M 346M 26.04M 25.49M 1.1B | 224M 11.91M 10.67M 9.85M 8.91M 16.66M 1.13B 16.93M 117M 46.86M 594M 44.71M 43.76M 1.88B |
| Net Debt | 3.26B 173M 155M 143M 130M 242M 16.5B 246M 1.71B 682M 8.64B 650M 637M 27.35B | 1.73B 92.22M 82.6M 76.2M 68.96M 129M 8.78B 131M 909M 363M 4.6B 346M 339M 14.56B |
Employees
7,754
Sector
Drug Retailers
- Stock Market
- Stocks
- BEVIDES B Stock
Select your edition
All financial news and data tailored to specific country editions
